Clinical Trial

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

Name: Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms — clinical trial record (NCT07693452)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendiceal mucinous neoplasms (AMNs).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-03.

Trial Details

NCT Number	NCT07693452
Lead Sponsor	University of California, Irvine
Conditions	Appendiceal Mucinous Neoplasm, Pseudomyxoma Peritonei
Enrollment	15 participants
Start Date	2026-06-18
Primary Completion	2028-02 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-13